Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:

| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | PDGFRαkinase-IN-2 is a potent inhibitor of PDGFR-α with an IC50 of 2.1 nM. It exhibits anticancer activity against human colon cancer HT-29 cells, with an IC50 of 1.48 μM. Additionally, PDGFRαkinase-IN-2 demonstrates anti-angiogenic properties in zebrafish models with low embryotoxicity, making it suitable for research in colon cancer and anti-angiogenesis. |
| Targets & IC50 | PDGFRα:2.1 nM |
| In vivo | PDGFRα kinase-IN-2 (Compound 6o) (0.1-10 μM, 72 h) significantly hinders the formation of zebrafish intersegmental vessels (ISV) in a dose-dependent manner and demonstrates superior anti-angiogenic activity compared to Sorafenib. Enpp-1-IN-27 (0.1-50 μM, 24 h) exhibits a particularly low lethality rate in zebrafish embryos and has a weaker effect than Sorafenib. |
| Molecular Weight | 429.47 |
| Formula | C24H23N5O3 |
| Cas No. | 3066103-58-7 |
| Smiles | O=C(NC1=CC=C(C=C1)NC=2N=CN=C3C=C(OC)C(OC)=CC32)NC4=CC=CC(=C4)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 µL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 µL Tween 80 and mix well until fully clarified.
3) Add 450 µL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.